AstraZeneca Strikes Up to $1.5 Billion AI Drug Discovery Deal With Insitro
The drugmaker will pay AI therapeutics company Insitro $40 million upfront and up to $1.46 billion subject to meeting targets.
Discussion
Rejoignez la communauté pour réagir et poser vos questions.
Aucun message pour l'instant. Lancez la discussion !